Skip to ContentSkip to Navigation
How to find us dr. ir. M.H. (Maaike) Oosterveer


Enantiomer-specific pharmacokinetics of D,L-3-hydroxybutyrate: Implications for the treatment of multiple acyl-CoA dehydrogenase deficiency

Exploiting epigenetics for the treatment of inborn errors of metabolism

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels

Macrophage NCOR1 protects from atherosclerosis by repressing a pro-atherogenic PPARĪ³ signature

Glucose-6-phosphate regulates hepatic bile acid synthesis in mice

Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR

The nuclear receptor corepressor 1 blocks CD36-mediated foam cell formation in atherogenesis

Next-generation glycogen storage diseases

Selective Glucocorticoid Receptor Modulation Prevents and Reverses Nonalcoholic Fatty Liver Disease in Male Mice

Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control

Read more


Academic carreer

Animal Testing